Key scientific issues in the health risk assessment of trichloroethylene

被引:56
作者
Chiu, Weihsueh A. [1 ]
Caldwell, Jane C. [1 ]
Keshava, Nagalakshmi [1 ]
Scott, Cheryl Siegel [1 ]
机构
[1] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Washington, DC 20460 USA
关键词
epidemiology; mode of action; peroxisome proliferators; pharmacokinetics; trichloroethylene; risk assessment;
D O I
10.1289/ehp.8690
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Trichloroethylene (TCE) is a common environmental contaminant at hazardous waste sites and in ambient and indoor air. Assessing the human health risks of TCE is challenging because of its inherently complex metabolism and toxicity and the widely varying perspectives on a number of critical scientific issues. Because of this complexity, the U.S. Environmental Protection Agency (EPA) drew upon scientific input and expertise from a wide range of groups and individuals in developing its 2001 draft health risk assessment of TCE. This scientific outreach, which was aimed at engaging a diversity of perspectives rather than developing consensus, culminated in 2000 with 16 stare-of-the-science articles published together as an Environmental Health Perspectives supplement. Since that time, a substantial amount of new scientific research has been published that is relevant to assessing TCE health risks. Moreover, a number of difficult or controversial scientific issues remain unresolved and are the subject of a scientific consultation with the National Academy of Sciences coordinated by the White House Office of Science and Technology Policy and co-sponsored by a number of federal agencies, including the U.S. EPA. The articles included in this minimonograph provide a scientific update on the most prominent of these issues: the pharmacokinetics of TCE and its metabolites, mode(s) of action and effects of TCE metabolites, the role of peroxisome proliferator-activated receptor in TCE toxicity, and TCE cancer epidemiology.
引用
收藏
页码:1445 / 1449
页数:5
相关论文
共 38 条
[1]  
[Anonymous], EPASABEHC03002
[2]  
[Anonymous], 1997, TOX PROF TRICHL
[3]  
[Anonymous], EPA600P01002A
[4]   Meta-analyses of TCE carcinogenicity [J].
Borak, J ;
Russi, M ;
Puglisi, JP .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 (12) :A542-A543
[5]   Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario [J].
Boyes, WK ;
Bushnell, PJ ;
Crofton, KM ;
Evans, M ;
Simmons, JE .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :317-322
[6]   Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma [J].
Brauch, H ;
Weirich, G ;
Hornauer, MA ;
Störkel, S ;
Wöhl, T ;
Brüning, T .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (10) :854-861
[7]   Renal cell carcinomas in trichloroethene(TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene [J].
Bruning, T ;
Weirich, G ;
Hornauer, MA ;
Hofler, H ;
Brauch, H .
ARCHIVES OF TOXICOLOGY, 1997, 71 (05) :332-335
[8]   Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate [J].
Bull, RJ .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :241-259
[9]  
CALWELL JC, 2006, ENV HLTH PERSPECT, V114, P1457
[10]   Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? [J].
Cattley, RC ;
DeLuca, J ;
Elcombe, C ;
Fenner-Crisp, P ;
Lake, BG ;
Marsman, DS ;
Pastoor, TA ;
Popp, JA ;
Robinson, DE ;
Schwetz, B ;
Tugwood, J ;
Wahli, W .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) :47-60